Donald Trump Britain city Oxford covid-19 prevention medicines patient Coronavirus Donald Trump Britain city Oxford

Coronavirus: UK to resume clinical trial of anti-malaria drug taken by Donald Trump

Reading now: 708
www.mirror.co.uk

A UK study on hydroxychloroquine will resume, just weeks after being halted. The trial will see healthcare workers given the anti-malarial drug, and will continue after getting approval to proceed from the UK Medicines Agency.

Dr Siu Ping Lam, Director of Licensing at the MHRA, said: "We have reviewed the University of Oxford’s request to recommence recruitment for the ‘COPCOV’ trial, investigating the use of hydroxychloroquine in the prevention of COVID-19. "After analysing the additional risk mitigations and consulting the Commission on Human Medicines, we have given the clinical trial the green light to recruit more participants. "Participant safety is our priority, so we will continue to monitor the trial to ensure ongoing appropriate

Read more on mirror.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA